FTSE 100
9.891,50
PKT
-8,10
PKT
-0,08
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.25 | Diageo Sector Perform | RBC Capital Markets | |
| 05.11.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 05.11.25 | BP Sector Perform | RBC Capital Markets | |
| 05.11.25 | RELX Outperform | Bernstein Research | |
| 05.11.25 | GSK Outperform | Bernstein Research | |
| 05.11.25 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.11.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | BP Kaufen | DZ BANK | |
| 04.11.25 | BP Sector Perform | RBC Capital Markets | |
| 04.11.25 | Rolls-Royce Buy | UBS AG | |
| 04.11.25 | GSK Hold | Deutsche Bank AG | |
| 04.11.25 | BP Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 03.11.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.11.25 | HSBC Neutral | UBS AG | |
| 03.11.25 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.11.25 | Diageo Buy | UBS AG | |
| 03.11.25 | Vodafone Group Sell | UBS AG | |
| 31.10.25 | AstraZeneca Buy | UBS AG | |
| 31.10.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 31.10.25 | BP Sector Perform | RBC Capital Markets | |
| 31.10.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 31.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 31.10.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 30.10.25 | GSK Halten | DZ BANK | |
| 30.10.25 | Rio Tinto Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 30.10.25 | GSK Hold | Deutsche Bank AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.10.25 | HSBC Sector Perform | RBC Capital Markets | |
| 30.10.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 29.10.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Hold | Deutsche Bank AG | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.10.25 | HSBC Overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.